Skip to main content
Clinical Trials/IRCT2017101331487N5
IRCT2017101331487N5
Recruiting
Phase 1

Investigating the effects of dexmedetomidine infusion during surgery on renal function parameters in patients receiving kidney transplantation

Vice-chancellor for Research, Iran University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
End-stage renal disease.
Sponsor
Vice-chancellor for Research, Iran University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice-chancellor for Research, Iran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • \- end stage renal disease (ESRD) patients
  • \- candidate for renal transplant
  • \- graft from living donor
  • \- age from 18 to 70 years old
  • Exclusion criteria:
  • \- bradycardia (HR\<50\)
  • \- hypotension (SBP\<100\)
  • \- ejection fraction below 30% (EF\<30%)
  • \- transplant from cadaver
  • \- simultaneous transplantation of kidney and pancreas

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials